{"url_path":"/sec/aytu/8-k/2026-05-13/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1385818/0001437749-26-016717-index.html","accession_number":"0001437749-26-016717","cik":"0001385818","ticker":"AYTU","issuer_name":"AYTU BIOPHARMA, INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1385818/0001437749-26-016717-index.html","primary_entity_key":"0001385818","primary_entity_name":"AYTU BIOPHARMA, INC"},"word_count":80,"has_tables":true,"body_markdown":"**Item 9.01 Financial Statements and Exhibits.**\n\n \n\n**(d) Exhibits.**\n\n \n\n**Exhibit Number**\n\n \n\n**Exhibit Description**\n\n99.1\n\n \n\n[Press Release dated May 13, 2026](ex_918589.htm)\n\n104\n\n \nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n \n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\nAYTU BIOPHARMA, INC.\n\n \n \n\n \n \n\nDate: May 13, 2026\n\nBy:\n\n/s/ Ryan J. Selhorn\n\n \n \n\nRyan J. Selhorn\n\n \n \n\nChief Financial Officer"}